Your SlideShare is downloading. ×
0
Ambroxol Presentation
Ambroxol Presentation
Ambroxol Presentation
Ambroxol Presentation
Ambroxol Presentation
Ambroxol Presentation
Ambroxol Presentation
Ambroxol Presentation
Ambroxol Presentation
Ambroxol Presentation
Ambroxol Presentation
Ambroxol Presentation
Ambroxol Presentation
Ambroxol Presentation
Ambroxol Presentation
Ambroxol Presentation
Ambroxol Presentation
Ambroxol Presentation
Ambroxol Presentation
Ambroxol Presentation
Ambroxol Presentation
Ambroxol Presentation
Ambroxol Presentation
Ambroxol Presentation
Ambroxol Presentation
Ambroxol Presentation
Ambroxol Presentation
Ambroxol Presentation
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Ambroxol Presentation

549

Published on

Mucolytic Expectorant

Mucolytic Expectorant

Published in: Health & Medicine, Technology
1 Comment
0 Likes
Statistics
Notes
  • Be the first to like this

No Downloads
Views
Total Views
549
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
32
Comments
1
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Presentation on Winkof Ambroxol Hydrocloride BP Presented by Md. Wahid Rezwan Executive, PMD Chemist Laboratories Ltd. Cell: 880001716356956 E-mail: rezwanwahid@gmail.com
  • 2. Executive Summary Brand Name : Winkof Generic Name : Ambroxol Hydrochloride BP Therapeutic Class : Mucoactive Agent Dosage Form : Syrup Strength : 100ml Flavor : Banana
  • 3. Winkof Carton
  • 4. Winkof Sticker
  • 5. General Information Winkof (Ambroxol Hydrochloride) is a Mucoactive agent used in the treatment of respiratory diseases associated with excessive mucus.
  • 6. Mucus Mucus is a slippery secretion produced by mucus membranes. It is a normal protective layering around the airway, eye and urinary tract. Mucus is an adhesive gel produced in the airway by submucosal glands and goblet cells and is principally water. Mucous cells on the stomach lining
  • 7. Phlegm Phlegm is more related to disease than is mucus. Phlegm is a secretion in the airway during disease and inflammation. Phlegm usually contains mucus with bacteria, dust. Once phlegm has been expectorated by a cough it becomes sputum.
  • 8. Cilia Cilia are short, hair-like, rhythmically beating organelles on the surface of certain cells. It moves or expels fluids, abnormal phlegm , dust particles and microbes by their conveyor belt like action.
  • 9. Cilia
  • 10. Cilia
  • 11. Cough A cough is a sudden and often repetitively occurring reflex which helps to clear the large breathing passages from secretions, irritants, foreign particles and microbes. Classification: 1. Non Productive cough ( Dry Cough ) 2. Productive cough ( Wet cough )
  • 12. Winkof Ambroxol Hydrochlorid BP
  • 13. Drugs of Respiratory System
  • 14. Product Information Winkof is a preparation of Ambroxol Hydrochloride. It possesses both Expectorant & Mucolytic effects. It increases bronchial secretion and decreases viscosity to make coughs more productive. It dilutes the thick mucus in the respiration track and facilitates excretion of it.
  • 15. Indications • Acute I Chronic Bronchitis Gi Kvi‡b m„ó k¦vmZ‡š¿i Cough `~i K‡i| • Laryngitis, Pharyngitis, Sinusitis BZ¨vw` †iv‡Mi Kvi‡b m„ó Cough, ey‡K e¨v_v I Mjvi e¨v_v `~i K‡i| • Asthmatic Bronchitis Gi Kvi‡b m„ó njy` ev meyR Cough, ey‡K e¨v_v I k¦vmKó `~i K‡i| • Bronchiectasis Gi Kvi‡b m„ó `~M©Ühy³ njy` ev meyR Cough `~i K‡i| • Chronic Pneumonia Gi Kvi‡b m„ó Nb Cough, ey‡K e¨v_v I k¦vmKó `~i K‡i|
  • 16. Mechanism of Action Winkof Expectorant Mucolytic Increases the bronchial secretion Breakdown of Acid Mucopolysaccharide Fiber Lubricate the irritated Respiratory Tract Thinner & Watery mucus Increased mucus flow by cilia through coughing
  • 17. Dosage Adult (Above 10years) : 10ml ( 2 Spoonful ) 2-3times Child : (5-10 Years) : 5ml (1 Spoonful) 2-3times (2-5 Years) : 2.5ml (1/2 Spoonful) 2-3times (1-2 Years) : 1.5ml 2times (6-12 Months) : 1ml 2times (0-6 months) : 0.5ml (2 times daily)
  • 18. Current Market situation :   Market Size Cr. TK.   Growth % Market Share 115.51 68.78 33.91   COUGH & COLD PREPARATIONS   EXPECTORANTS      AMBROXOL 19.56 13.55 12.93 13.91 59.54 49.30 Brand Name Company AMBROX SQUARE 15.95 12.82 47.04 BOXOL OPSONIN 4.32 63.79 12.77 AMBOLYT INCEPTA 4.23 35.71 12.48 LYTEX IBN SINA 1.62 9.53 4.79 MYROX ACI 1.04 -31.14 3.09      
  • 19. SWOT Analysis Strengths 1. We have more than 700 Field Force. 2. We’ve Dynamic Leaders like you 3. We have 555 Doctors (MBBS& above) 4. We have 593 Doctors (Below MBBS) Opportunities 1. High growth rate market. 2. Better than Cough Suppressants 3. We’ve got Winter Season Weaknesses 1. 2. 3. 4. Late entry Poor product knowledge No list of Specialized Doctors Lack of monitoring. Threats 1. Aggressive competitor activity
  • 20. Qualitative :  Make Winkof as an Established Brand by creating complete Brand Awareness.  To hold a Good Position in the market.  Proper use of Promo Materials.
  • 21. Quantitative : Monthly Sales target : Brand Sales/Month (Unit) Sales/Month (Tentative Value) Winkof 30,000 7.5 Lac
  • 22. Rx Analysis Category Number of FF Exp. Rx / Day Est. Rx/ Month A 100 3 7,200 B 150 2 7,200 C 200 1 4,800 Total 450 1.78 19,200 Total Tentative Value/ Month If 100% of Trader’s sales = 13.5 Lac If 30% System loss = 10 Lac 6.72 Lac
  • 23. Target Doctors • Chest Specialists • Medicine Specialists • Child Specialists • GPs • RMPs/PCs As well as Chemist Shop
  • 24. Monitoring Activities     Ensure 100% utilization of Logistics and Samples. Gifts must be distributed through Joint Call (By Leader + Promoter). Strict monitoring and emphasizing on poor performance Area. Maintain Daily Communication with Team Leader.
  • 25. THANKS

×